Delayed peak serum valproic acid in massive divalproex overdose - Treatment with charcoal hemoperfusion

被引:34
作者
Graudins, A
Aaron, CK
机构
[1] Univ. of Massachusetts Med. Center, Worcester, MA
[2] Division of Toxicology, Department of Emergency Medicine, Univ. of Massachusetts Med. Center, Worcester, MA 01655
来源
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1996年 / 34卷 / 03期
关键词
D O I
10.3109/15563659609013799
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Background: increased clearance and apparent clinical improvement in valproic acid overdose has been reported following in-series hemodialysis/hemoperfusion therapy. We report a case of divalproex sodium and chlorpheniramine overdose treated with charcoal hemoperfusion and multiple-dose activated charcoal. Case Report: A 32-year-old female presented alert three hours postingestion of her own medication. Serum valproic acid was 105 mu g/mL. No anticholinergic toxicity was seen. Despite three doses of activated charcoal over 14 hours, serum valproic acid continued to rise. Whole bowel irrigation and multiple-dose activated charcoal were commenced 17 h postingestion when serum valproic acid was 1380 mu g/mL. Charcoal hemoperfusion was instituted three hours later when serum valproic acid had not fallen and the patient remained obtunded. Results: Initial extraction ratio of the hemoperfusion cartridge was 0.54 with plasma clearance of 54.5 mL/min. Valproic acid elimination half-life was 3 h during the 190 min hemoperfusion cycle. Posthemoperfusion elimination half-life was 4.8 h with continued multiple-dose activated charcoal dosing. The clinical condition improved during hemoperfusion. Conclusion: Enteric coated valproic acid preparations may cause delayed toxicity in overdose, particularly with coingested anticholinergic medications. In our case, charcoal hemoperfusion appeared to increase valproic acid clearance.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 17 条
[1]   LIFE-THREATENING INTOXICATION WITH SODIUM VALPROATE [J].
ANDERSEN, GO ;
RITLAND, S .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1995, 33 (03) :279-284
[2]   CONCENTRATION-EFFECT RELATIONSHIPS OF VALPROIC ACID [J].
CHADWICK, DW .
CLINICAL PHARMACOKINETICS, 1985, 10 (02) :155-163
[3]   ACUTE VALPROIC ACID OVERDOSE - CLINICAL COURSE AND PHARMACOKINETIC DISPOSITION OF VALPROIC ACID AND METABOLITES [J].
DUPUIS, RE ;
LICHTMAN, SN ;
POLLACK, GM .
DRUG SAFETY, 1990, 5 (01) :65-71
[4]   ACUTE VALPROIC ACID INTOXICATION - ENHANCED DRUG CLEARANCE WITH ORAL-ACTIVATED CHARCOAL [J].
FARRAR, HC ;
HEROLD, DA ;
REED, MD .
CRITICAL CARE MEDICINE, 1993, 21 (02) :299-301
[5]   A CASE OF VALPROATE INTOXICATION WITH EXCESSIVE BRAIN EDEMA [J].
HINTZE, G ;
KLEIN, HH ;
PRANGE, H ;
KREUZER, H .
KLINISCHE WOCHENSCHRIFT, 1987, 65 (09) :424-427
[6]   THE EFFECT OF HEMODIALYSIS AND HEMOPERFUSION ON SERUM VALPROIC ACID CONCENTRATION [J].
KANDROTAS, RJ ;
LOVE, JM ;
GAL, P ;
OLES, KS .
NEUROLOGY, 1990, 40 (09) :1456-1458
[7]  
KARLSEN RL, 1983, ACTA MED SCAND, V213, P405
[8]   CEREBRAL EDEMA FOLLOWING ACUTE SODIUM VALPROATE OVERDOSE [J].
KHOO, SH ;
LEYLAND, MJ .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1992, 30 (02) :209-214
[9]  
KLOTZ U, 1977, CLIN PHARMACOL THER, V21, P736
[10]  
MORTENSEN PB, 1983, INT J CLIN PHARM TH, V21, P64